Baxter (BAX) sees early weakness

October 20, 2026 10:05 AM EDT Send to a Friend
Baxter (NYSE: BAX) sees early weakness which could be related to an FDA warning letter related to an inspection of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login